✦ LIBER ✦

Infliximab for severe hidradenitis suppurativa: Transient clinical efficacy in 7 consecutive patients

✍ Scribed by Laurence Fardet; Alain Dupuy; Delphine Kerob; Annabelle Levy; Matthieu Allez; Edouard Begon; Hervé Bachelez; Patrice Morel; Celeste Lebbé

Book ID: 116581997
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 164 KB
Volume: 56
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2006.07.027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double-blind, placebo-controlled, cros

A double-blind, placebo-controlled, crossover trial to assess the efficacy and safety of infliximab for patients with moderate to severe hidradenitis suppurativa

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Long-term efficacy and safety results (6

Long-term efficacy and safety results (60 weeks) of a double-blind, placebo-controlled, crossover trial of infliximab for patients with moderate to severe hidradenitis suppurativa

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 41 KB